Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDS
Karin D. Prummel(European Molecular Biology Laboratory), Borhane Guezguez(German Cancer Research Center), Evi P. Vlachou(European Molecular Biology Laboratory), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Maksim Kholmatov(University of Basel), Pedro Luís Moura(Integrated Cardio Metabolic Centre), Kevin E. Woods(Cancer Treatment Centers of America), Judith B. Zaugg(European Molecular Biology Organization), Logan S. Schwartz(Tufts University), Susann Winter(University Hospital Carl Gustav Carus), Kai Stühler(Düsseldorf University Hospital), Marc Schmitz(Berlin-Brandenburger Centrum für Regenerative Therapien), Jennifer J. Trowbridge(Jackson Laboratory), Uwe Platzbecker(National Center for Tumor Diseases), Gereon Poschmann(Düsseldorf University Hospital), Rebekka Wehner(Technische Universität Dresden), Eva Hellström-Lindberg(Karolinska Institutet), Matthias Theobald(Johannes Gutenberg University Mainz)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
|Nature|2015|925
Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
|Journal of Clinical Oncology|2001|898